Skip to main content

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

UTHR holding history

United Therapeutics Corp in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

UTHR overviewAll 13F holders of UTHRFull Q2 2026 holdings

Shares (Q2 2026)
7,508
Value
$4.07M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of UTHR by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,508$4.07M<0.1%−274−3.5%ReducedHolders
Q1 20267,782$4.61M<0.1%+1,121+16.8%AddedHolders
Q4 20256,661$3.25M<0.1%−1,022−13.3%ReducedHolders
Q3 20257,683$3.22M<0.1%+241+3.2%AddedHolders
Q2 20257,442$2.14M<0.1%+25+0.3%AddedHolders
Q1 20257,417$2.29M<0.1%+67+0.9%AddedHolders
Q4 20247,350$2.59M<0.1%+605+9.0%AddedHolders
Q3 20246,745$2.42M<0.1%−134−1.9%ReducedHolders
Q2 20246,879$2.19M<0.1%−838−10.9%ReducedHolders
Q1 20247,717$1.77M<0.1%+2,116+37.8%AddedHolders
Q4 20235,601$1.23M<0.1%+7+0.1%AddedHolders
Q3 20235,594$1.26M<0.1%−105−1.8%ReducedHolders
Q2 20235,699$1.26M<0.1%−407−6.7%ReducedHolders
Q1 20236,106$1.37M<0.1%+73+1.2%AddedHolders
Q4 20226,033$1.68M<0.1%+622+11.5%AddedHolders
Q3 20225,411$1.13M<0.1%−27−0.5%ReducedHolders
Q2 20225,438$1.28M<0.1%+399+7.9%AddedHolders
Q1 20225,039$904.0K<0.1%−18−0.4%ReducedHolders
Q4 20215,057$1.09M<0.1%−58−1.1%ReducedHolders
Q3 20215,115$944.0K<0.1%−174−3.3%ReducedHolders
Q2 20215,289$949.0K<0.1%+559+11.8%AddedHolders
Q1 20214,730$791.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.